Literature DB >> 2780757

Bioadhesive dosage form for peroral administration of timolol base.

P B Deasy, C T O'Neill.   

Abstract

Timolol base was prepared from its maleate salt and checked for purity, pKa (9.03) and n-octanol/phosphate buffer pH 6.6 partition coefficient (1.72). The rate of swelling of sodium carboxymethylcellulose, Carbopol 934 (CP) and hydroxypropylcellulose (HPC) was examined prior to use in bioadhesive compacts with the model drug methylene blue to study their influence on device integrity and drug diffusion. A final compact containing a core of timolol base and Precirol, a bioadhesive layer of CP and HPC, and a cap of magnesium stearate gave sustained release of the drug in simulated saliva pH 6.6. After preliminary evaluation in dogs, the compact was evaluated in a panel of humans in whom it was shown that the flux of drug could be increased from 70 to 127 micrograms mm-2 h-1 by inclusion of the penetration enhancer sodium lauryl-sulphate into the core formulation.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2780757

Source DB:  PubMed          Journal:  Pharm Acta Helv        ISSN: 0031-6865


  4 in total

1.  Comparison of salivary miconazole concentrations after administration of a bioadhesive slow-release buccal tablet and an oral gel.

Authors:  S Bouckaert; H Schautteet; R A Lefebvre; J P Remon; R van Clooster
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

Review 2.  Novel oral drug formulations. Their potential in modulating adverse effects.

Authors:  A T Florence; P U Jani
Journal:  Drug Saf       Date:  1994-03       Impact factor: 5.606

3.  Preparation and evaluation of buccal bioadhesive films containing clotrimazole.

Authors:  S Singh; S Jain; M S Muthu; S Tiwari; R Tilak
Journal:  AAPS PharmSciTech       Date:  2008-05-24       Impact factor: 3.246

4.  Formulation and Evaluation of In-vitro Characterization of Gastic-Mucoadhesive Microparticles/Discs Containing Metformin Hydrochloride.

Authors:  Fatemeh Khonsari; Parvin Zakeri-Milani; Mitra Jelvehgari
Journal:  Iran J Pharm Res       Date:  2014       Impact factor: 1.696

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.